作者:A. K. Brel’、A. A. Spasov、S. V. Lisina、S. S. Popov、A. F. Kucheryavenko、R. A. Litvinov、O. A. Salaznikova、A. I. Rashchenko
DOI:10.1007/s11094-019-02029-5
日期:2019.9
A series of N1, N3-bis-hydroxybenzoyl, -acetoxybenzoyl, and -methoxybenzoyl uracil derivatives were synthesized. All compounds were screened for the ability to rupture protein cross links and antiglycating, chelating, and antiaggregant properties, which are most significant for pharmacological treatment of thrombosis and angio-, nephro-, encephalo-, and cardiopathies. 1,3-bis-(4-Methoxybenzoyl)pyrimidine-2,4(1H,3H)-dione was a promising antidiabetic agent with all studied activities.
一系列N1、N3-双羟基苯甲酰基、-乙酰氧基苯甲酰基和-甲氧基苯甲酰基尿嘧啶衍生物被合成。所有化合物均被筛选其破坏蛋白质交联、抗糖化、螯合和抗聚集性质的能力,这些特性在治疗血栓和血管、肾脏、脑部及心脏疾病等药理学处理中最为重要。1,3-双-(4-甲氧基苯甲酰基)吡啶-2,4(1H,3H)-二酮是一种有潜力的抗糖尿病药物,具备所有研究中的活性。